Using data from a multi-hospital clinical network to explore prevalence of pediatric rickets in Kenya

Stella W Karuri1, Maureen K Murithi1, Grace Irimu1

  • 1Kenya Medical Research Institute-Wellcome Trust Research Programme, Nairobi, Kenya.

Wellcome Open Research
|October 25, 2017
PubMed

Insights

Nutritional rickets shows significant regional variation in Kenyan hospitals, with higher prevalence in Nairobi. Rickets is linked to malnutrition and longer hospital stays, necessitating targeted public health interventions.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Nutritional rickets remains a significant public health issue globally, affecting both developing and developed nations.
  • Understanding regional variations in pediatric rickets prevalence is crucial for effective health interventions.

Purpose of the Study:

  • To determine the hospital-based prevalence of rickets in children across three regions in Kenya: Central Kenya, Western Kenya, and Nairobi County.
  • To investigate the association of rickets with malnutrition and pneumonia in pediatric admissions.
  • To analyze the impact of rickets on hospital length of stay.

Main Methods:

  • Analysis of pediatric discharge records (1 month to 5 years) from the Clinical Information Network (CIN) between February 2014 and February 2015.
  • Statistical assessment of associations using odds ratios and Fisher exact test.
  • Kaplan-Meier curves employed to evaluate hospital stay durations.

Main Results:

  • Nairobi County exhibited the highest rickets prevalence (4.01%), followed by Central Kenya (0.92%). Western Kenya reported only one case.
  • Rickets showed a significant association with malnutrition, with regional variations in this link.
  • Pneumonia was associated with rickets in Central Kenya. Children with rickets experienced longer hospital stays, independent of malnutrition and pneumonia.

Conclusions:

  • Marked regional disparities in hospital-based rickets prevalence highlight the need for tailored public health strategies.
  • Factors including maternal/child nutrition, urbanization, and cultural practices may contribute to observed regional differences.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
730
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
338
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
289
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
359
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
258
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.0K